StockData
GLAUKOS Corp logo

GLAUKOS Corp (GKOS) stock

GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30215% above fair value
$243.25−1.63 (-0.67%)

Close on Nov 17, 2026Market cap $14.40BP/E –Yield –

Glaukos pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Glaukos's pe ratio was 163.2× on Jul 29, 2022, against 824.4× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Jul 29, 2022163.2×+64.0
2020Apr 30, 202099.2×−266.1
2017Jul 31, 2017365.3×−320.7
2016Dec 30, 2016686.0×–

More Glaukos figures

See a number that looks wrong?